About knowadhd

knowadhd publishes plain language educational material on attention-deficit / hyperactivity disorder and the Indian healthcare and regulatory landscape that surrounds it. The site is built around a few observations that anyone who has lived this in India will recognise.

First, the available content online is mostly written for Western readers. The clinical research often translates; the cost numbers, the legal context, the family dynamics, the way Indian schools handle neurodevelopmental conditions, the actual experience of trying to fill a methylphenidate prescription at an Indian chemist - none of that translates without effort.

Second, the high-volume Indian content that does exist tends to fall into one of two camps: brand marketing for a clinic or app, or social-media simplifications that turn a complex clinical picture into a personality quiz. Neither is fundamentally wrong, but neither is what a careful reader needs.

Third, the regulatory layer matters in India in a way it does not elsewhere. The reason your local pharmacy will not stock methylphenidate, the reason tele-consultation cannot prescribe stimulants, the reason your insurer treats mental healthcare differently from physical healthcare, the reason your child's school does not implement formal accommodations, all of these have specific legal explanations that are worth understanding.

That is the gap this site tries to fill.

What we publish

Editorial standards

Independence

knowadhd does not accept paid product placements. There are no clinic partnerships, no app affiliate links, no sponsored articles. The site has no investors. If a sustainable model becomes necessary, it will be disclosed clearly and will not change editorial decisions.

What this site is not

knowadhd is not a clinic. It does not consult, diagnose, prescribe, or treat. It is not a referral service. The current version does not collect personal data. For clinical care, please consult a qualified medical practitioner. For legal questions about your specific situation, please consult a lawyer.

Corrections

Editorial corrections, source suggestions, and review requests from qualified clinicians or lawyers are welcome. A contact pathway will be added in a later version of the site, with the consent and data-handling mechanisms required by the Digital Personal Data Protection Act, 2023.